Table 4.
uHI | tHI | CR | ||||
---|---|---|---|---|---|---|
n = 75 | n = 15 | n = 16 | ||||
npos | %neg [95% CI] | npos | %neg [95% CI] | npos | %neg [95% CI] | |
STTT | ||||||
Ser-RL | 5 | 93 [85 − 98] | 2 | 87 [60 − 98] | 0 | 100 [80 − 100] |
Lia-RL | 5 | 93 [85 − 98] | 2 | 87 [60 − 98] | 0 | 100 [80 − 100] |
C6-RL | 4 | 95 [87 − 99] | 0 | 100 [78 − 100] | 0 | 100 [80 − 100] |
Ser-EU | 8 | 89 [80 − 95] | 2 | 87 [60 − 98] | 5 | 69 [41 − 89] |
Lia-EU | 8 | 89 [80 − 95] | 2 | 87 [60 − 98] | 4 | 75 [48 − 93] |
C6-EU | 4 | 95 [87 − 99] | 0 | 100 [78 − 100] | 1 | 94 [70 − 100] |
MTTT | ||||||
Ser-Lia | 9 | 88 [78 − 94] | 2 | 87 [60 − 98] | 4 | 75 [48 − 93] |
Ser-C6 | 5 | 93 [85 − 98] | 0 | 100 [78 − 100] | 1 | 94 [70 − 100] |
Lia-C6 | 5 | 93 [85 − 98] | 0 | 100 [78 − 100] | 2 | 88 [62 − 98] |
uHI: untreated healthy individuals, tHI: treated healthy individuals, CR: cross-reactivity controls, Ser: Serion, Lia: Liaison, C6: C6 Lyme ELISA, RL: recomLine, EU: Euroline, STTT: standard two-tier testing, MTTT: modified two-tier testing